Tuberculosis mutation discovery could lead to better treatments
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
List view / Grid view
Gene Therapy is the introduction of normal genes into cells in place of missing or defective ones in order to correct genetic disorders.
New gene mutation discovery could lead to more rapid and effective therapies for tuberculosis.
A study has used CRISPR-Cas9 to treat obesity and type 2 diabetes symptoms in mice, highlighting the potential use in humans.
Researchers have created a new technique for activating genes using bacteria which could have therapeutic uses.
A new technique called ‘ubiquitin clipping’ has been created which could aid proteomics research and the development of new drugs for ubiquitination.
Scientists report how editing a portion of stem cells with CRISPR-Cas9 is sufficient for long-term reactivation of therapeutic haemoglobin.
Newly developed HDO-antimiR could lead to new ways to treat diseases which are caused by malfunctioning miRNAs.
Researchers have successfully used a no-cut CRISPR gene editing technique as a therapy for muscular dystrophy in mice models.
Researchers have extended the life of heart segments from 24 hours to six days, enabling pre-clinical trials to experiment on these new models for longer periods of time.
A study has used new synthetic lipids to deliver CRISPR gene editing tools into cells with up to 90 percent efficiency.
Researchers have generated images of CRISPR-Cas9 gene editing for the first time, enabling improvement of the technique.
Research from Oregon Health & Science University could lead to new therapies to heal nervous system disorders.
New method for directed evolution could improve gene therapies and generic drug development.
A new study has used combined therapies to eliminate HIV from mice models, providing potential future cures.
Researchers have analysed the physical origin and biological consequences of DNA-RNA hybrids which could inform gene therapies.
A recent study has identified the DBC1 gene which leaves cancer cells more exposed to therapies.